APHERION THERAPEUTICS LIMITED
🌱Startupactive
16879736 · ltd · incorporated 2025-11-28
Investment thesis
Established operating company — standard diligence applies, no dominant angle.
Why interesting: Live, filing, normal profile.
Why risky: No standout signals in either direction.
🔒Estimated value
—
Upgrade to see
Turnover
—
not disclosed
Net worth
—
book net assets
Opportunity
70/100
Strong
What this business does
Primary activity: Research and experimental development on biotechnology
Sector: Professional, scientific & technical
Investor take
PursueStrong opportunity: active trading company with strong profile and acceptable with review structure.
Opportunity 70/100 (strong), bankability 65/100. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (63/100).
Data confidence
Overall: medium (55/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Company profile
address, 1 SIC codes, incorporation date
100
Financials
No iXBRL financials extracted
0
Lenders & charges
Confirmed no charges registered
85
Directors & officers
3 officers (3 active, 3 linked, 3 with DOB)
90
Ownership & PSC
2 active PSC(s) of 4 total, 4 with control declared
90
Director network
Network not yet resolved
30
Filing history
11 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
70/100Strong
PassWatchWorth a lookStrongExceptional
Solid opportunity signal. Worth a dedicated memo and management meeting.
Business quality
60
Adequate — check latest filings for context.
Acquirability
50
Some acquirability indicators.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.
Recent activity
Last 30 days
0
filings
Last 90 days
0
filings
Last 180 days
10
filings
- • 4 persons-with-significant-control
- • 2 officers
- • 1 incorporation
Counts from Companies House filing history.
Corporate timeline (15 events)Click to expand
- 2026-03-30📄memorandum-articlesincorporation · MA
- 2026-03-20📄resolutionresolution · RESOLUTIONS
- 2026-03-16📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC02
- 2026-03-16📄cessation-of-a-person-with-significant-controlpersons-with-significant-control · PSC07
- 2026-03-16📄cessation-of-a-person-with-significant-controlpersons-with-significant-control · PSC07
- 2026-03-16📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC01
- 2026-03-16📄appoint-person-director-company-with-name-dateofficers · AP01
- 2026-03-10📄appoint-person-director-company-with-name-dateofficers · AP01
- 2026-03-10📄capital-allotment-sharescapital · SH01
- 2026-03-09➕BOYLE, Robert George appointeddirector
- 2026-03-09➕SIMPSON, Gavin Alexander appointeddirector
- 2026-02-27📄change-account-reference-date-company-current-shortenedaccounts · AA01
- 2025-11-28🏢Company incorporatedAs APHERION THERAPEUTICS LIMITED
- 2025-11-28➕DIGNAN, James Maxwell appointeddirector
- 2025-11-28📄incorporation-companyincorporation · NEWINC
Owner dependency
55/100
Moderate — manageable with handoverSome founder dependency, but not acute. A structured handover period should cover most risk.
FACTORS
- +Young company: Only 0.7 years old — management layer unlikely to be developed.
Succession & seller-readiness
30/100
Weak signalLimited succession signal. Not a near-term off-market candidate.
Red flags
cleanNo red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)
Group structure
Sentinel Oncology Limited holds 25-50% — a significant corporate investor but not a controlling parent.
🏛️significant stake
Sentinel Oncology Limited
Corporate parent · holds 25-50% shares
⬇
APHERION THERAPEUTICS LIMITED
This company · 16879736
Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).
Shareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Gavin Alexander Simpson Individual · British · DOB 09/1971 · age 55 | 25–50% | — | 25-50% shares | 09/03/2026 |
Sentinel Oncology Limited Corporate entity | 25–50% | — | 25-50% shares | 09/03/2026 |
2 historic (ceased) PSCs
- Mr James Maxwell Dignanceased 09/03/2026· 50-75% shares · 50-75% voting · board control
- Mr Grahame Mckenzieceased 09/03/2026· 25-50% shares · 25-50% voting
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Professional services · CB postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ALPHUBEL LTD→ 12541436 · est 2020 · no financials extracted | — | — | — | — | 6y | — | — |
| ANGLIAN ACCOUNTING SUPPORT LTD→ 07612731 · est 2011 · no financials extracted | — | — | — | — | 14y | — | — |
| ANGLICA CONSULTANCY LTD→ 16371372 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| ANNE LARKIN LIMITED→ 09599457 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
| ANTARCTIC SCIENCE→ 03927089 · est 2000 · no financials extracted | — | — | — | — | 26y | — | — |
| ANTOMAD LTD→ 12426140 · est 2020 · no financials extracted | — | — | — | — | 6y | — | — |
| APK ARCHITECTURE & DESIGN LTD→ 12417504 · est 2020 · no financials extracted | — | — | — | — | 6y | — | — |
| APM PAPWORTH SERVICES LTD→ 11660343 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| APOIDEA LIMITED→ 12000830 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| APOLLO AP04 LIMITED→ 13594883 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| APOLLO AP05 LIMITED→ 13735245 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| APOLLO AP08 LIMITED→ 13594874 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →🔒Advanced scoring suite
Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Statusactive
Typeltd
Incorporated2025-11-28
Jurisdictionengland-wales
Primary SIC72110 — Research and experimental development on biotechnology
Registered office
181 Cambridge Science Park
Milton Road
Cambridge
CB4 0GJ
United Kingdom
Filing status
Accounts
Next due: 2026-12-31
Last made up to: —
Confirmation statement
Next due: 2026-12-11
Last: —
Officers (3 active · 0 resigned)
BOYLE, Robert George→
Activedirector · ~55y · appointed 2026-03-09
View their other companies + combined net worth →
DIGNAN, James Maxwell→
Activedirector · ~47y · appointed 2025-11-28
View their other companies + combined net worth →
SIMPSON, Gavin Alexander→
Activedirector · ~55y · appointed 2026-03-09
View their other companies + combined net worth →
Click a director name to see their full track record across all companies.
Recent filings (11 total)
memorandum-articles
incorporation · MA
2026-03-30
resolution
resolution · RESOLUTIONS
2026-03-20
notification-of-a-person-with-significant-control
persons-with-significant-control · PSC02
2026-03-16
cessation-of-a-person-with-significant-control
persons-with-significant-control · PSC07
2026-03-16
cessation-of-a-person-with-significant-control
persons-with-significant-control · PSC07
2026-03-16
notification-of-a-person-with-significant-control
persons-with-significant-control · PSC01
2026-03-16
appoint-person-director-company-with-name-date
officers · AP01
2026-03-16
appoint-person-director-company-with-name-date
officers · AP01
2026-03-10
capital-allotment-shares
capital · SH01
2026-03-10
change-account-reference-date-company-current-shortened
accounts · AA01
2026-02-27
incorporation-company
incorporation · NEWINC
2025-11-28